Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments ...

Oil prices edged higher on Tuesday as better-than-expected U.S. manufacturing activity data spurred hope for a post-pandemic economic recovery, and as analysts forecast a sixth weekly drawdown in U.S.

The move is part of a broader push to onshore pharmaceutical production and reduce reliance on foreign suppliers, ...

European drugmakers will struggle to bring production back to the region, but the industry needs to diversify supplies to avoid shortages, a top EU official said on Wednesday, as worries grow about ...

Though details of the 100% tariff on branded drugs remain unclear, these stocks have already seen a reaction from investors.

The US administration has been weighing duties on pharma drugs and APIs under Section 232, which is used to investigate ...

Earnings cuts prelude to Q2 FY26 results season, regulatory deficit turns India's pharma strength into a weakness, peace in ...

A local nonprofit working to strengthen the U.S. drug ingredient supply chain says external forces are making drug shortages ...

Through the FDA's ANDA scheme, drug manufacturers who test and produce their generic medicines on US soil can now seek ...

The United States has grown its dependent on foreign drug supplies from China and India,, causing a national security and ...

In August, the agency announced a new program called FDA PreCheck, 2 which is designed to increase regulatory predictability ...

AstraZeneca’s $4.5B Virginia facility will create 3,600+ jobs and expand production of innovative treatments for chronic ...